James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why SolarCity Corp (SCTY), Norwegian Cruise Line Holdings Ltd (NCLH) and Nokia Corp (NOK) Are 3 of Today’s Worst Stocks

Nokia (NOK), SolarCity Corp (SCTY) and Norwegian Cruise Line Holdings Ltd (NCLH) never even had a prayer of bullishness for Tuesday.

Alphabet Inc: Is There Any Meaningful Upside in GOOGL Stock?

Alphabet (GOOGL, GOOG) is going to have a tough time clearing a big technical ceiling, but swing traders are loving it.

Why JD.Com Inc(ADR) (JD), LendingClub Corp (LC) and ArcelorMittal SA (ADR) (MT) Are 3 of Today’s Worst Stocks

LendingClub (LC), ArcelorMittal SA (MT) and JD.Com (JD) dished out nothing but pain on an otherwise-meaningless day.

Chipotle Mexican Grill, Inc. (CMG) Is Its Own Worst Enemy

Chipotle Mexican Grill (CMG) got belligerent with the Centers for Disease Control, only highlighting how desperate the restaurateur has become.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Is Making a Comeback

Teva Pharmaceuticals (TEVA) may be a long-term buy here at depressed levels, with an upcoming deal poised to drive underappreciated growth.